Aleglitazar Lowers the Triglyceride/high-density Lipoprotein Cholesterol Ratio in Patients With Type 2 Diabetes Mellitus
Year: 2012
Type: article
Institution: Cleveland Clinic
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1967397140
